Clinical Trial

Opioid Sparing Effect of Sphenopalatine Ganglion Block in Functional Endoscopic Sinus Surgery: a Randomized Controlled Clinical Trial.

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Functional endoscopic sinus surgery (FESS) is widely recognized as a safe and preferred treatment option for various conditions, particularly nasal polyps and rhinosinusitis . This technique has been shown to improve postoperative symptoms by 86.3% in patients with chronic inflammatory paranasal sinus diseases . The aim of this study is to evaluate the effect of adding of MgSO4 to bupivacaine via SPGB block for postoperative pain for 24 hours in patients scheduled for FESS as opioid free anaesthesia.
Trial Details
NCT Number NCT06752525
Lead Sponsor Assiut University
Conditions Sinus Surgery
Enrollment 60 participants
Start Date 2025-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-30